TW266207B - - Google Patents
Info
- Publication number
- TW266207B TW266207B TW083107863A TW83107863A TW266207B TW 266207 B TW266207 B TW 266207B TW 083107863 A TW083107863 A TW 083107863A TW 83107863 A TW83107863 A TW 83107863A TW 266207 B TW266207 B TW 266207B
- Authority
- TW
- Taiwan
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21158993 | 1993-08-26 | ||
| JP234194 | 1994-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW266207B true TW266207B (zh) | 1995-12-21 |
Family
ID=26335705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083107863A TW266207B (zh) | 1993-08-26 | 1994-08-26 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5710150A (zh) |
| EP (1) | EP0716083A4 (zh) |
| KR (1) | KR100340145B1 (zh) |
| CN (2) | CN1040748C (zh) |
| AU (1) | AU684537B2 (zh) |
| CA (1) | CA2170373A1 (zh) |
| FI (1) | FI960867A (zh) |
| HU (1) | HUT73526A (zh) |
| NO (1) | NO308896B1 (zh) |
| NZ (1) | NZ271454A (zh) |
| PL (1) | PL182011B1 (zh) |
| RU (1) | RU2137760C1 (zh) |
| TW (1) | TW266207B (zh) |
| WO (1) | WO1995006035A1 (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW486370B (en) * | 1996-12-25 | 2002-05-11 | Yamanouchi Pharma Co Ltd | Rapidly disintegrable pharmaceutical composition |
| AR011913A1 (es) * | 1997-03-06 | 2000-09-13 | Yamano Masaki | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. |
| AU2001267911A1 (en) * | 2000-07-04 | 2002-01-14 | Yamanouchi Pharmaceutical Co..Ltd. | Pharmaceutical compositions for treatment of diabetic nephropathy |
| ES2288899T3 (es) | 2000-10-04 | 2008-02-01 | Astellas Pharma Inc. | Uso de un antagonista de vasopresina tal como conivaptan en la fabricacion de un medicamento para el tratamiento de la hipertension pulmonar. |
| AU2002224115A1 (en) * | 2000-11-28 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4,5,6-tetrahydroimidazo(4,5-d)diazepine derivatives or salts thereof |
| IL159963A0 (en) * | 2001-08-09 | 2004-06-20 | Actelion Pharmaceuticals Ltd | Novel benzo-fused heterocycles as endothelin antagonisits |
| EP1445253B1 (en) * | 2001-11-16 | 2009-08-05 | Astellas Pharma Inc. | 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| WO2004096775A1 (ja) | 2003-04-28 | 2004-11-11 | Astellas Pharma Inc. | ４，４－ジフルオロ－１，２，３，４－テトラヒドロ－５ｈ－１－ベンゾアゼピン誘導体又はその塩 |
| ES2366641T3 (es) * | 2003-04-28 | 2011-10-24 | Astellas Pharma Inc. | Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o sal del mismo. |
| JP4765546B2 (ja) * | 2004-10-27 | 2011-09-07 | アステラス製薬株式会社 | ベンゾアゼピン誘導体又はその塩の製造法 |
| JP4765545B2 (ja) * | 2004-10-27 | 2011-09-07 | アステラス製薬株式会社 | ベンゾアゼピン誘導体を有効成分とする医薬組成物 |
| EP1908753B1 (en) | 2005-07-22 | 2014-12-17 | Mochida Pharmaceutical Co., Ltd. | Novel heterocyclidene acetamide derivative |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| PE20081692A1 (es) | 2007-01-24 | 2008-12-18 | Mochida Pharm Co Ltd | Nuevo derivado de heterocicliden acetamida |
| US20100016285A1 (en) * | 2007-01-24 | 2010-01-21 | Mochida Pharmaceutical Co., Ltd. | Heterocyclidene-n-(aryl) acetamide derivative |
| FR2969605A1 (fr) * | 2010-12-28 | 2012-06-29 | Univ Strasbourg | Derives de 2,3,4,5-tetrahydro-1h-benzo[b]azepine et leur utilisation |
| WO2019003433A1 (ja) * | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | ベンゾアゼピン誘導体 |
| JP6868089B2 (ja) * | 2018-12-28 | 2021-05-12 | 大塚製薬株式会社 | 医薬 |
| CN111187227B (zh) * | 2020-01-20 | 2020-10-23 | 河南农业大学 | 一种用于小麦全蚀病病菌抑制的2-(1,2,4-三氮唑)苯甲酰芳胺类活性化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6080641A (ja) * | 1983-10-12 | 1985-05-08 | 清水建設株式会社 | 石張材固定用アンカ−ボルトの埋設方法 |
| JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
| CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
| JPH05320135A (ja) * | 1992-05-19 | 1993-12-03 | Yamanouchi Pharmaceut Co Ltd | テトラヒドロベンズアゼピン誘導体 |
| JP2969207B2 (ja) * | 1992-07-02 | 1999-11-02 | 大塚製薬株式会社 | オキシトシン拮抗剤 |
| JP2961291B2 (ja) * | 1992-08-20 | 1999-10-12 | 大塚製薬株式会社 | ベンゾヘテロ環化合物 |
| JPH0680641A (ja) * | 1992-09-01 | 1994-03-22 | Otsuka Pharmaceut Co Ltd | 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法 |
| JP2913082B2 (ja) * | 1992-10-16 | 1999-06-28 | 大塚製薬株式会社 | バソプレシン拮抗剤及びオキシトシン拮抗剤 |
-
1994
- 1994-08-25 RU RU96107125/04A patent/RU2137760C1/ru not_active IP Right Cessation
- 1994-08-25 PL PL94313252A patent/PL182011B1/pl unknown
- 1994-08-25 AU AU75084/94A patent/AU684537B2/en not_active Ceased
- 1994-08-25 CA CA002170373A patent/CA2170373A1/en not_active Abandoned
- 1994-08-25 EP EP94925007A patent/EP0716083A4/en not_active Withdrawn
- 1994-08-25 WO PCT/JP1994/001409 patent/WO1995006035A1/ja not_active Application Discontinuation
- 1994-08-25 CN CN94193169A patent/CN1040748C/zh not_active Expired - Fee Related
- 1994-08-25 HU HU9600427A patent/HUT73526A/hu unknown
- 1994-08-25 KR KR1019960700927A patent/KR100340145B1/ko not_active IP Right Cessation
- 1994-08-25 NZ NZ271454A patent/NZ271454A/en unknown
- 1994-08-26 TW TW083107863A patent/TW266207B/zh active
-
1996
- 1996-02-23 NO NO960722A patent/NO308896B1/no unknown
- 1996-02-26 US US08/607,217 patent/US5710150A/en not_active Expired - Fee Related
- 1996-02-26 FI FI960867A patent/FI960867A/fi unknown
-
1997
- 1997-09-22 CN CN97119206A patent/CN1064042C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5710150A (en) | 1998-01-20 |
| CN1198437A (zh) | 1998-11-11 |
| FI960867A0 (fi) | 1996-02-26 |
| HUT73526A (en) | 1996-08-28 |
| CN1064042C (zh) | 2001-04-04 |
| AU684537B2 (en) | 1997-12-18 |
| NO960722L (no) | 1996-04-26 |
| CA2170373A1 (en) | 1995-03-02 |
| NO960722D0 (no) | 1996-02-23 |
| RU2137760C1 (ru) | 1999-09-20 |
| EP0716083A1 (en) | 1996-06-12 |
| AU7508494A (en) | 1995-03-21 |
| CN1129934A (zh) | 1996-08-28 |
| EP0716083A4 (en) | 1996-08-28 |
| CN1040748C (zh) | 1998-11-18 |
| KR100340145B1 (ko) | 2002-10-18 |
| PL182011B1 (en) | 2001-10-31 |
| KR960703865A (ko) | 1996-08-31 |
| NZ271454A (en) | 1997-07-27 |
| HU9600427D0 (en) | 1996-04-29 |
| PL313252A1 (en) | 1996-06-24 |
| NO308896B1 (no) | 2000-11-13 |
| WO1995006035A1 (fr) | 1995-03-02 |
| FI960867A (fi) | 1996-02-26 |